Literature DB >> 27821982

Comparative Study of Mifepristone with Vaginal Misoprostol for First Trimester Termination of Pregnancy at Different Gestational Ages.

Seema Rani Meena1.   

Abstract

METHODS: This study for medical abortion was conducted in the Department of Obstetrics and Gynaecology, Zenana Hospital, SMS Medical College, Jaipur during 2011-2012. In total 280 cases were taken for the study and divided into two groups, among whom there were six defaulters in each group who failed to present for follow-up.
OBJECTIVES: The objectives of this study were to (1) compare the success rates of abortion at different gestational ages, (2) study the side effects of the drugs, and (3) study the acceptability in both the groups.
RESULTS: The medical abortion with the given regimen and protocol was observed to be highly successful, and complete abortion was achieved in 98.51 and 97.76 % of the patients in Group-A and Group-B, respectively. Failure rates observed were only 1.49 % in Group-A and 2.24 % in Group-B.
CONCLUSIONS: Medical abortion can be safely performed in cases up to 63 days of gestation, but women should be counseled about the increased blood loss and duration of bleeding.

Entities:  

Keywords:  MTP; Mifepristone; Termination of pregnancy

Year:  2015        PMID: 27821982      PMCID: PMC5080213          DOI: 10.1007/s13224-015-0705-x

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  3 in total

1.  Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.

Authors:  H Kopp Kallner; C Fiala; O Stephansson; K Gemzell-Danielsson
Journal:  Hum Reprod       Date:  2010-02-19       Impact factor: 6.918

2.  Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial.

Authors:  M D Creinin; J L Schwartz; H C Pymar; W Fink
Journal:  BJOG       Date:  2001-05       Impact factor: 6.531

3.  An effective regimen for early medical abortion: a report of 2000 consecutive cases.

Authors:  P W Ashok; G C Penney; G M Flett; A Templeton
Journal:  Hum Reprod       Date:  1998-10       Impact factor: 6.918

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.